Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases

Multilevel N2 patients can be grouped according to the prognostic factors cN2 and PM. These findings have potential for evaluating the best therapeutic modalities or agents for multilevel N2 patients.